Wellington Management Group LLP Ascendis Pharma A/S Transaction History
Wellington Management Group LLP
- $551 Billion
- Q1 2024
A detailed history of Wellington Management Group LLP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Wellington Management Group LLP holds 2,745,872 shares of ASND stock, worth $374 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,745,872Holding current value
$374 Million% of portfolio
0.08%Shares
18 transactions
Others Institutions Holding ASND
# of Institutions
211Shares Held
46.5MCall Options Held
310KPut Options Held
306K-
Artisan Partners Limited Partnership Milwaukee, WI5.67MShares$774 Million1.32% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.08MShares$556 Million3.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.97MShares$541 Million7.23% of portfolio
-
Janus Henderson Group PLC London, X03.77MShares$514 Million0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.57MShares$350 Million0.24% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.61B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...